Basic Information
RNALocate ID: | RLID:11002757 |
RNA Symbol: | hsa-miR-20b-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-20b-5p |
RNA ID: | miRBase:MIMAT0001413 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23663360 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002278 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01002279 | Cytoplasm | Neural progenitor cells | 21363885 |
RLID:01002280 | Mitochondrion | Cell line (HEK-293) | 22984580 |
RLID:01002281 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01002282 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01002283 | Nucleus | Colon adenocarcinoma cells | 20864815 |
RLID:11002753 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11002754 | Exosome | Ovarian follicular fluid | 22116803 |
RLID:11002755 | Exosome | Breast milk | 22211110 |
RLID:11002756 | Exosome | Brain tissue | 23382797 |
RLID:11002758 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11002759 | Microvesicle | Seminal plasma | 23539611 |
RLID:11002760 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000138 | Exosome | Seminal fluid | |
RLID-D:11000451 | Microvesicle | Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-20b-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-27920 |
MNDR | hsa-miR-20b-5p | Oral squamous cell carcinoma | MNDR-E-MI-27921 |
MNDR | hsa-miR-20b-5p | Large cell neuroendocrine cancer | MNDR-E-MI-27922 |
MNDR | hsa-miR-20b-5p | Medulloblastoma | MNDR-E-MI-27923 |
MNDR | hsa-miR-20b-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-27924 |
MNDR | hsa-miR-20b-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-27925 |
MNDR | hsa-miR-20b-5p | Lymphoma | MNDR-E-MI-27926 |
MNDR | hsa-miR-20b-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-27927 |
MNDR | hsa-miR-20b-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-27928 |
MNDR | hsa-miR-20b-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-27929 |
MNDR | hsa-miR-20b-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-27930 |
MNDR | hsa-miR-20b-5p | Her2-receptor positive breast cancer | MNDR-E-MI-27931 |
MNDR | hsa-miR-20b-5p | Breast cancer luminal | MNDR-E-MI-27932 |
MNDR | hsa-miR-20b-5p | Dermatomyositis | MNDR-E-MI-27933 |
MNDR | hsa-miR-20b-5p | Prostate cancer | MNDR-E-MI-27934 |
MNDR | hsa-miR-20b-5p | Gastric cancer | MNDR-E-MI-27935 |
MNDR | hsa-miR-20b-5p | Alzheimer disease | MNDR-E-MI-27936 |
MNDR | hsa-miR-20b-5p | Intracranial aneurysm | MNDR-E-MI-27937 |
MNDR | hsa-miR-20b-5p | Bladder cancer | MNDR-E-MI-27938 |
MNDR | hsa-miR-20b-5p | Esophageal carcinoma | MNDR-E-MI-27939 |
MNDR | hsa-miR-20b-5p | Dysautonomia familial | MNDR-E-MI-27940 |
MNDR | hsa-miR-20b-5p | Leukemia | MNDR-E-MI-27941 |
MNDR | hsa-miR-20b-5p | Friedreich ataxia | MNDR-E-MI-27942 |
MNDR | hsa-miR-20b-5p | Cardiovascular disease | MNDR-E-MI-27943 |
MNDR | hsa-miR-20b-5p | Carotid stenosis | MNDR-E-MI-27944 |
MNDR | hsa-miR-20b-5p | Lung cancer | MNDR-E-MI-27945 |
MNDR | hsa-miR-20b-5p | Parkinson disease | MNDR-E-MI-27946 |
MNDR | hsa-miR-20b-5p | Basal-like breast cancer | MNDR-E-MI-27947 |
MNDR | hsa-miR-20b-5p | Thyroid cancer | MNDR-E-MI-27948 |
MNDR | hsa-miR-20b-5p | Pancreatic cancer | MNDR-E-MI-27949 |
MNDR | hsa-miR-20b-5p | Melanoma | MNDR-E-MI-27950 |
MNDR | hsa-miR-20b-5p | Rectum adenocarcinoma | MNDR-E-MI-27951 |
MNDR | hsa-miR-20b-5p | Nephroblastoma | MNDR-E-MI-27952 |
MNDR | hsa-miR-20b-5p | Colon cancer | MNDR-E-MI-27953 |
MNDR | hsa-miR-20b-5p | Ischemic attack transient | MNDR-E-MI-27954 |
MNDR | hsa-miR-20b-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-27955 |
MNDR | hsa-miR-20b-5p | Prostate adenocarcinoma | MNDR-E-MI-27956 |
MNDR | hsa-miR-20b-5p | Kidney cancer | MNDR-E-MI-27957 |
MNDR | hsa-miR-20b-5p | Carcinoma ductal breast | MNDR-E-MI-27958 |
MNDR | hsa-miR-20b-5p | Glioblastoma | MNDR-E-MI-27959 |
MNDR | hsa-miR-20b-5p | Astrocytoma | MNDR-E-MI-27960 |
MNDR | hsa-miR-20b-5p | Glioma | MNDR-E-MI-27961 |
MNDR | hsa-miR-20b-5p | Central nervous system lymphoma | MNDR-E-MI-27962 |
MNDR | hsa-miR-20b-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-27963 |
MNDR | hsa-miR-20b-5p | Osteosarcoma | MNDR-E-MI-27964 |
MNDR | hsa-miR-20b-5p | Liposarcoma | MNDR-E-MI-27965 |
MNDR | hsa-miR-20b-5p | Liver cancer | MNDR-E-MI-27966 |
MNDR | hsa-miR-20b-5p | Cervical adenocarcinoma | MNDR-E-MI-27967 |
MNDR | hsa-miR-20b-5p | Gastric adenocarcinoma | MNDR-E-MI-27968 |
MNDR | hsa-miR-20b-5p | Cervical squamous cell carcinoma | MNDR-E-MI-27969 |
MNDR | hsa-miR-20b-5p | Lung squamous cell carcinoma | MNDR-E-MI-27970 |
MNDR | hsa-miR-20b-5p | Non-small cell lung adenocarcinoma | MNDR-E-MI-27971 |
MNDR | hsa-miR-20b-5p | Lung adenocarcinoma | MNDR-E-MI-27972 |
MNDR | hsa-miR-20b-5p | Adrenocortical cancer | MNDR-E-MI-27973 |
MNDR | hsa-miR-20b-5p | Thyroid carcinoma | MNDR-E-MI-27974 |
MNDR | hsa-miR-20b-5p | Ovarian carcinoma | MNDR-E-MI-27975 |
MNDR | hsa-miR-20b-5p | Myasthenia gravis | MNDR-E-MI-27976 |
MNDR | hsa-miR-20b-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-27977 |
MNDR | hsa-miR-20b-5p | Carcinoma renal cell | MNDR-E-MI-27978 |
MNDR | hsa-miR-20b-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-27979 |
MNDR | hsa-miR-20b-5p | Clear cell renal cell carcinoma | MNDR-E-MI-27980 |
MNDR | hsa-miR-20b-5p | Biliary tract cancer | MNDR-E-MI-27981 |
MNDR | hsa-miR-20b-5p | Cholangiocarcinoma | MNDR-E-MI-27982 |
MNDR | hsa-miR-20b-5p | Esophageal cancer | MNDR-E-MI-27983 |
MNDR | hsa-miR-20b-5p | Lung small cell carcinoma | MNDR-E-MI-27984 |
MNDR | hsa-miR-20b-5p | Synovial sarcoma | MNDR-E-MI-27985 |
MNDR | hsa-miR-20b-5p | Testicular germ cell cancer | MNDR-E-MI-27986 |
MNDR | hsa-miR-20b-5p | T acute lymphoblastic leukemia | MNDR-E-MI-27987 |
MNDR | hsa-miR-20b-5p | Acute t cell leukemia | MNDR-E-MI-27988 |
MNDR | hsa-miR-20b-5p | Heart failure | MNDR-E-MI-27989 |
MNDR | hsa-miR-20b-5p | Breast invasive carcinoma | MNDR-E-MI-27990 |
MNDR | hsa-miR-20b-5p | Hepatocellular carcinoma | MNDR-E-MI-27991 |
MNDR | hsa-miR-20b-5p | B-cell lymphoma | MNDR-E-MI-27992 |
MNDR | hsa-miR-20b-5p | T-cell leukemia | MNDR-E-MI-27993 |
MNDR | hsa-miR-20b-5p | Malignant pleural mesothelioma | MNDR-E-MI-27994 |
MNDR | hsa-miR-20b-5p | Neuroblastoma | MNDR-E-MI-27995 |
MNDR | hsa-miR-20b-5p | Barrett's adenocarcinoma | MNDR-E-MI-27996 |
MNDR | hsa-miR-20b-5p | Hodgkin lymphoma | MNDR-E-MI-27997 |
MNDR | hsa-miR-20b-5p | Colorectal cancer | MNDR-E-MI-27998 |
MNDR | hsa-miR-20b-5p | Nasopharynx carcinoma | MNDR-E-MI-27999 |
MNDR | hsa-miR-20b-5p | Multiple myeloma | MNDR-E-MI-28000 |
MNDR | hsa-miR-20b-5p | Esophageal squamous cell carcinoma | MNDR-E-MI-28001 |
MNDR | hsa-miR-20b-5p | Uterine cervical neoplasms | MNDR-E-MI-28002 |
MNDR | hsa-miR-20b-5p | Ependymoma | MNDR-E-MI-28003 |
MNDR | hsa-miR-20b-5p | Nasopharyngeal cancer | MNDR-E-MI-28004 |
MNDR | hsa-miR-20b-5p | Prostatic neoplasms | MNDR-E-MI-28005 |
MNDR | hsa-miR-20b-5p | Pseudorabies | MNDR-E-MI-28006 |
MNDR | hsa-miR-20b-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-28007 |
MNDR | hsa-miR-20b-5p | Gait ataxia | MNDR-E-MI-28008 |
MNDR | hsa-miR-20b-5p | Stroke lacunar | MNDR-E-MI-28009 |
MNDR | hsa-miR-20b-5p | Barrett's carcinogenesis | MNDR-E-MI-28010 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | AC021078.1 | Homo sapiens | RR00029797 |
TOP